217 companies

Ascendis Pharma

Market Cap: US$10.5b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

ASND

US$174.18

7D

0.7%

1Y

29.8%

Alnylam Pharmaceuticals

Market Cap: US$43.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALNY

US$331.91

7D

4.3%

1Y

33.5%

AVITA Medical

Market Cap: US$143.6m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

RCEL

US$5.42

7D

5.9%

1Y

-30.4%

Lumentum Holdings

Market Cap: US$6.4b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

LITE

US$92.75

7D

-2.1%

1Y

71.0%

Alkami Technology

Market Cap: US$3.2b

Provides cloud-based digital banking solutions in the United States.

ALKT

US$30.64

7D

1.8%

1Y

1.3%

Circle Internet Group

Market Cap: US$43.0b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

CRCL

US$188.77

7D

-11.6%

1Y

n/a

TG Therapeutics

Market Cap: US$5.4b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

TGTX

US$36.72

7D

-3.2%

1Y

95.4%

Ardelyx

Market Cap: US$1.0b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX

US$4.27

7D

15.9%

1Y

-19.7%

Super Micro Computer

Market Cap: US$29.0b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

SMCI

US$48.56

7D

-1.4%

1Y

-42.7%

Mereo BioPharma Group

Market Cap: US$456.3m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

MREO

US$2.87

7D

2.5%

1Y

-20.1%

Legend Biotech

Market Cap: US$6.6b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

LEGN

US$35.64

7D

6.5%

1Y

-22.4%

Blueprint Medicines

Market Cap: US$8.3b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

BPMC

US$128.35

7D

0.2%

1Y

17.7%

Alvotech

Market Cap: US$2.8b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

ALVO

US$9.19

7D

-2.4%

1Y

-24.4%

Palantir Technologies

Market Cap: US$317.1b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

PLTR

US$134.36

7D

-6.9%

1Y

419.8%

Capricor Therapeutics

Market Cap: US$468.5m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

CAPR

US$10.25

7D

0.7%

1Y

112.2%

TruGolf Holdings

Market Cap: US$63.5m

Through its subsidiary, engages in the design, development, manufacture, and sale of golf simulators for residential and commercial applications in the United States.

TRUG

US$5.93

7D

-6.5%

1Y

-88.9%

ARS Pharmaceuticals

Market Cap: US$1.6b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

SPRY

US$16.52

7D

-8.6%

1Y

81.7%

Achieve Life Sciences

Market Cap: US$112.2m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

ACHV

US$2.18

7D

-37.9%

1Y

-51.7%

Travere Therapeutics

Market Cap: US$1.3b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

TVTX

US$15.01

7D

-0.8%

1Y

89.0%

Aldeyra Therapeutics

Market Cap: US$257.6m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

ALDX

US$4.30

7D

11.1%

1Y

34.4%

Madrigal Pharmaceuticals

Market Cap: US$6.6b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

MDGL

US$298.87

7D

-0.2%

1Y

10.0%

Vanda Pharmaceuticals

Market Cap: US$292.9m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$4.97

7D

3.1%

1Y

-7.3%

Roadzen

Market Cap: US$78.0m

Operates an Insurtech company in India, the United States, the United Kingdom, and Europe.

RDZN

US$1.05

7D

-0.9%

1Y

-61.8%

Soleno Therapeutics

Market Cap: US$4.4b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

SLNO

US$86.65

7D

3.1%

1Y

106.2%

Abeona Therapeutics

Market Cap: US$301.3m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

ABEO

US$5.89

7D

-0.2%

1Y

35.4%

Tenaya Therapeutics

Market Cap: US$99.5m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

TNYA

US$0.61

7D

-11.5%

1Y

-79.0%

UroGen Pharma

Market Cap: US$626.1m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

URGN

US$13.58

7D

3.6%

1Y

-9.5%

TeraWulf

Market Cap: US$2.0b

Operates as a digital asset technology company in the United States.

WULF

US$5.26

7D

19.8%

1Y

1.0%

Nutanix

Market Cap: US$20.6b

Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.

NTNX

US$76.80

7D

2.0%

1Y

31.0%

ACADIA Pharmaceuticals

Market Cap: US$3.5b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ACAD

US$20.95

7D

-5.7%

1Y

34.4%

Gorilla Technology Group

Market Cap: US$398.4m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

GRRR

US$21.15

7D

-0.8%

1Y

686.2%

RenovoRx

Market Cap: US$49.7m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

RNXT

US$1.36

7D

0.7%

1Y

21.4%

Spotify Technology

Market Cap: US$148.7b

Provides audio streaming subscription services worldwide.

SPOT

US$725.05

7D

-6.6%

1Y

130.3%

Workday

Market Cap: US$64.5b

Provides enterprise cloud applications in the United States and internationally.

WDAY

US$241.76

7D

1.9%

1Y

7.2%

Zscaler

Market Cap: US$49.0b

Operates as a cloud security company worldwide.

ZS

US$314.77

7D

0.3%

1Y

58.7%

Similarweb

Market Cap: US$738.5m

Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.

SMWB

US$8.84

7D

14.2%

1Y

19.3%

Page 1 of 7